Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs subcutaneous insulin lispro bolus dosing in type 1 diabetes
2010-019161-28Phase 2Completed
- Sponsor
- BD
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of insulin lispro in diabetes mellitus type 1 (T1D) (2 arms), sponsored by BD. Primary endpoint: Post-prandial time in range glucose levels. Started Mar 2010; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-019161-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019161-28.